CoAmox-Acino 1000
CoAmox-Acino 1000 is a medicine authorised by Swissmedic under authorisation number 62850. The authorisation holder is Acino Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 25 March 2013 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 62850 |
|---|---|
| Name | CoAmox-Acino 1000 |
| Full name | CoAmox-Acino 1000, Filmtabletten |
| Authorisation holder | Acino Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | not stated |
| First authorisation | 25 March 2013 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | CoAmox-Acino 1000, Filmtabletten | A | 25 March 2013 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| The Swissmedic export lists no pack sizes for this medicine. | |||||
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is CoAmox-Acino 1000 authorised in Switzerland?
Yes. CoAmox-Acino 1000 is authorised by Swissmedic under authorisation number 62850, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does CoAmox-Acino 1000 have?
CoAmox-Acino 1000 is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of CoAmox-Acino 1000?
The authorisation holder is Acino Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.